key: cord-0803437-jxmdkafl authors: Roncati, Luca; Bergonzini, Giuliano; Lusenti, Beatrice; Nasillo, Vincenzo; Paolini, Ambra; Zanelli, Giuliana; Corrado, Stefania title: High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a T(h)2 response due to severe COVID-19 date: 2020-08-28 journal: Ann Hematol DOI: 10.1007/s00277-020-04231-y sha: ce9c2dfbad24b89deaac1c12e64068b6bce61fae doc_id: 803437 cord_uid: jxmdkafl nan Coronavirus disease 2019 (COVID-19) is a global health emergency without precedents, that is causing hundreds of thousands of victims and impairing, to some extent, the quality of life of those patients survived to the most severe form of the disease [1, 2] . In this regard, a 67-year-old male patient was admitted to the intensive care unit for bilateral pneumonia from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, as proven by nasopharyngeal swab positivity. The clinical picture was so serious that endotracheal intubation and then tracheostomy were required; despite all, the patient was saved, and he was discharged from the hospital. Three and a half months after admission, a second hospitalization was necessary due to complex subglottic stenosis, and the surgical resection of a tracheal ring was performed. Besides exuberant fibrosis, histology and immunohistochemistry revealed a high localized density of immunoglobulin G4 (IgG4)-secreting plasma cells inside the fibrotic tissue ( Fig. 1) ; contrariwise, IgG4 dosage on serum was found within the normal range (43 mg/dL). As well known, IgG4-related disease (IgG4-RD) is a chronic immune-mediated condition, which occurs most frequently in middle-aged and elderly men, characterized by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, various degrees of storiform fibrosis, and a usually prompt improvement by oral steroids [3] . The connective deposition in the affected anatomical site can lead to mass-forming tumor-like lesions and organ dysfunctions [3] . Severe SARS-CoV-2 infections are associated with marked T cytotoxic (T c ) lymphopenia [4] , and, in these life-threatening cases, the immune system is forced to mount a T helper 2 (T h 2) response (humoral immunity), the only one still mountable in the attempt to counteract the viral load, rather than a T helper 1 response (cell-mediated immunity), which would keep the infection under control by means of T c lymphocytes and macrophages [5] [6] [7] [8] . Because regulation of IgG4 switching is dependent by T h 2 cells [9] , it is possible that the T h 2 response, induced by serious SARS-CoV-2 infections, triggers in some patients a localized IgG4 hyperproduction with subsequent scarring sequelae, in particular at the level of the respiratory tract, even in the absence of IgG4-RD. In addition, since advanced age, male sex, and chronic comorbidities are risk factors for COVID-19 mortality [10] , IgG4-RD patients appear at higher risk of progressing to critical state once infected, and thus need to be identified and properly managed. Conflict of interest The authors declare that they have no conflict of interest. Ethical approval All procedures followed were in accordance with the ethical standards and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent Not applicable since the manuscript does not contain any patient data. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation Reninangiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2 Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and metaanalysis Signals of Th2 immune response from COVID-19 patients requiring intensive care Type 3 hypersensitivity in COVID-19 vasculitis The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19 What about the original antigenic sin of the humans versus SARS-CoV-2? Immunoglobulin G4: an odd antibody Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors and outcomes Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations